Khrom Capital Management, one of the largest shareholders of Acadia Healthcare, has called on the company’s board to launch a formal strategic review, including a potential sale, citing years of poor performance and governance failures. The investment manager, in a letter to the company’s board, also highlighted eroding shareholder confidence in leadership and incremental changes that are no longer sufficient, Acadia said. The investor criticized the company’s board for a lack of accountability, citing long director tenures, minimal stock ownership and delayed governance reforms.
Read the full article: Khrom Capital Urges Acadia Healthcare to Explore Sale After ‘Lost Decade’ //
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/khrom-capital-urges-acadia-healthcare-explore-sale-2025-10-01/